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Background:  To analyze skin manifestations in 
patients with diabetes mellitus  
Methods: This cross sectional study was conducted 
on 100 consecutive patients of Diabetes Mellitus 
type 1 &2, either attending the out-patients 
departments of Dermatology and Medicine or 
admitted in medical wards of Cantonment General 
Hospital, Rawalpindi from 1st January 2017 to 30th 
June 2017. Both male and female patients aged 
between 15-80 years were included in the study. 
Results: Out of hundred patients, skin changes 
were present in 64%. The common disorders were 
skin infections in 43 patients, pruritis in 17, and  
skin tags in 15 patients. Other manifestations were 
lichen planus in 5, diabetic foot in 5, acanthosis 
nigricans in 4, eruptive xanthomas in 3, eczema in 3, 
vitiligo in 2, diabetic dermopathy in 1, xerosis in 1 
and psoriasis in 1 patient. 
Conclusion: Skin involvement is quite common in 
diabetes. It can manifest as first sign or may 
manifest at any time during the course of disease so 
it is important to identify and appropriately treat 
these patients. 
Key Words: Diabetes Mellitus, Skin 
manifestations, Skin disorders. 
 
Introduction 
Skin disorders are mostly neglected and frequently 
under-diagnosed in diabetic patients.Diabetes mellitus 
(DM) is a syndrome characterized by a high serum 
glucose level and disturbed carbohydrate and lipid 
metabolism due to relative insulin deficiency, insulin 
resistance or both.1 This increase in the incidence of 
DM is due to population growth, aging, urbanization, 
and increasing prevalence of obesity and physical 
inactivity.2 Type-2 diabetes mellitus (T2DM) is 
expanding at an epidemic rate and it is most common 
endocrine problem with serious health concerns.3-6  
Diabetes can affect every organ of the body including 
the skin.7,8 Skin manifestations can develop in almost 
30% of all diabetics.8  Dermatological problems can 
appear during the course of disease in already known 
diabetic patients or it may be the first presenting sign 
in newly diagnosed patients. It can even precede the 
diagnosis by many years thus, giving a clue to 
clinicians.8Both type-1 diabetes mellitus(T1DM) & 
T2DM patients can develop cutaneous disorders. 
Autoimmune disorders like acanthosis nigricans (AN), 
necrobiosis lipoidica (NL), diabetic dermopathy, 
scleredema, and granuloma annulare, or infectious in 
the form of erythrasma, necrotizing fasciitis, and 
mucormycosis  are more common in T1DM while 
cutaneous infections are more common in  
T2DM.8,9Female patients generally had increased 
frequency of acanthosis nigricans. Skin tags are also 
more commonly found in diabetics, probably due to 
hyperinsulinemia and higher glycated haemoglobin 
(HbA1c) levels.3 Diabetic dermopathy is considered as 
pathognomonic of diabetes.10Pruritus can be an initial 
symptom of DM.11 
Eruptive xanthomas (EX) are the lesions, observed in 
patients with poor control of diabetes and 
hypertriglyceridemia, most commonly found over the 
buttocks, elbows and knees. NL is a dermatosis of 
unknown origin, characteristically occurring in 
patients with diabetes. Vitiligo is a chronic disease of 
autoimmune etiology that is characterized by an 
absence/malfunctioning of melanocytes resulting in 
hypo or achromic spots surrounded by normal skin 
seen in T1DM.13 Apart from these commonly 
described diabetic markers, a correlation has been 
found between psoriasis and T2DM.3 Although skin 
manifestations occur commonly in diabetes, there is 
marked variability in outcomes among different study 
populations due to difference in climate and hygienic 
conditions across the country which can affect the 
results.  
 
Patients and Methods 
This study was conducted at the out-patients 
departments of Dermatology and Medicine and on 
those patients admitted in medical wards of 
Cantonment General Hospital, Rawalpindi from  
January to June 2017. 100 consecutive patients of 
T1DM and T2DM already diagnosed according to the 
WHO diagnostic criteria were included in the study. 
Patients aged between 15-80 years were included. 
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Patients younger than 15 years or those suffering from 
vasculitis, hypercholesteremia, malignancies, 
gestational diabetes, and thyroid-related disorders or 
taking any drug affecting the skin were excluded. 
After taking informed consent, complete history and 
detailed examination was done. Data was collected on 
a proforma. Continuous variables like age were 
expressed as Mean ± S.D and categorical variables like 
gender, types of skin lesions and skin infections etc. 
were presented in the form of frequencies and 
percentages.   
 
Results 
There were 32% males (M: F=1:2.1). The youngest 
patient was 28 years and the oldest was 80 years with 
a mean age of 57.44 ± 10.37 years. The duration of 
diabetes was < 10 years in 56 patients. 26 patients had 
11-20 years of diabetes, and 10 had > 20 years of 
diabetes. 8 patients were newly diagnosed as diabetics. 
6 patients have type 1 and 94 patients have type 2 
diabetes mellitus (Table 1). Skin manifestations were 
found in 64 (64%) of patients. Out of these, 3 T1DM 
had skin manifestations and 61 patients of T2DM had 
skin lesions. Majority of patients (35%) had  one type 
of lesion , two types of lesion were found in 23%,  
while 6% had  three lesions (Table 1).The most 
frequent finding was skin infections found in 43 
patients .Majority of patients had fungal infections i.e. 
26 patients (Fig.1) while 9 patients had furuncles and  
carbuncles, 6 patients presented with cellulitis and 
only 2 had folliculitis. Second most common finding 
was pruritis in 17 patients. Skin tags were present in 15 
and lichen planus was present in 5 patients. Diabetic 
foot was present in 5 patients along with numbness & 
paresthesias but none of them had amputation. 
Acanthosis nigricans was found in 4 patients (Fig.2). 
Eczema and eruptive xanthomas over upper eyelids 
were found in three patients each. Vitiligo was seen in 
two patients while diabetic dermopathy, xerosis and 
psoriasis were present in only one patient each (Table 
2).  
Table 1.  General characteristics of diabetic 
patients (with or without cutaneous manifestations) 
Characteristics Specific cutaneous 
disorders 
Total Present Absent 
Total patients (n=100) 64 36 
Males (n=32) 15 17 
Females (n= 68) 49 19 
Type 1 Diabetes (n=6) 3 3 
Type 2 Diabetes (n=94) 61 33 
Table 2. Types of skin lesions in diabetes 
mellitus. 
Type of skin lesions Number of patients 
Infections  43 
Bacterial infection 17 
Cellulitis 6 
Fruncles & carbuncles 9 
Folliculitis 2 
Fungal infection 26 
Candidal 12 
Onychomycosis 10 
Tinea corporis 4 
Pruritis  17 
Skin tags 15 
Lichen planus  5 
Diabetic foot  5 
Acanthosis nigricans  4 
Eruptive xanthomas 3 
Eczema  3 
Vitiligo  2 
Diabetic dermopathy 1 
Xerosis  1 
Psoriasis  1 
 
    




Diabetes mellitus (DM) is considered a modern 
epidemic disease that affects about 8.3% of the world’s 
population and 46% cases are estimated to be still 
undiagnosed.13 DM has extensive impact on human 
body but skin, despite being the largest organ in the 
body has received minimum attention and 
dermatological complications remained relatively 
under explored.14 
Skin manifestations has become more common with 
the increase in the prevalence of diabetes.7An overall 
prevalence of skin disorders in DM varied from 51.1 to 
97 % in different regions of the world.15 In our study, 
64% patients of DM had skin manifestations which is 
close to a study done at Lahore that found 58% 
patients with skin lesions16 but Khoharo et al did a 
study at Mirpur Khas showing 80% skin involvement 
in diabetic patients which shows marked variation.17 
Colour mPage 
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Majority of our patients 35(35%) had single type of 
skin lesion which is in contrast to study done by 
Furqan et al which showed that most patients had 
more than one lesion i.e. 30%.5 
The most frequent finding was skin infections in 43% 
of the patients. The prevalence of skin infections in 
other local studies was 30.9% and 72%.12,18 Fungal 
infections 26% were more common in our study than 
bacterial infections 17(17%) while Khoharo et al found 
more bacterial infections in 50% of the cases than 
fungal infections (16.6%).17 This variability in the 
incidence of various infections among patients of 
different regions of the country can be due to exposure 
to climatic and working conditions. 
The second most common finding was pruritis found 
in 17% cases. In a study conducted in Iran, the most 
common noninfectious manifestation also was pruritus 
.15 Local studies showed incidence of only 1.1%.5 Skin 
tags, most commonly associated with 
hyperinsulinemia, were present in 15% cases. Kahana 
et al did a study on 216 patients with skin tags and 
found DM in 57(26.3%) of the patients and 17 patients 
(7.9%) had impaired glucose tolerance test. Another 
study by Thappa et al had found diabetes in 62.8% of 
the patients with skin tags.9 
Lichen planus is an uncommon disorder affecting 2-
4% patients with T1DM or T2DM.7Lichen planus was 
found in 5% of cases in our study which is close to 
another local study which showed incidence of 
3.3%.17Diabetic foot was present in 5% patients. 
Similar incidence of 5.9% was found in other local 
study.5Acanthosis nigricans, usually seen in situations 
of insulin resistance and can be predictive for 
developing T2DM7 was found in 4% patients in our 
study. Bhat et al found AN in 5.3%9 of the diabetic 
patients but our local studies showed variable results 
of 5.8%17and 19%.5 
Eruptive Xanthomas  were found in 3% of the patients 
which is consistent with a local study done at 
Battagram showing incidence of 2.6%.18 These lesions 
can be the first sign of diabetes and occurs more in 
patients with poor control of T2DM.7 Eczema was 
found in 3(3%) of our patients. Sasmaz et al showed 
skin eczemas in 15.2 % patients of diabetes.15 Vitilgo is 
commonly associated with T1DM due to autoimmune 
nature of both diseases. It has a worldwide incidence 
of 0.3–0.5%.7 but we found in only2% cases. A local 
study showed incidence of 5.7% which is higher than 
our study.18The low incidence in our study might be 
due to only 6 patients with T1DM. 
Xerosis  was  found in one patient,  but study done at 
Mirpur Khas showed it in 5% patients.17 Xerosis 
showed high heterogeneity and international studies 
showed a high incidence of xerosis 44 % as its 
prevalence may be affected not only by the type of DM 
but also by the regional changes in climate and 
humidity.15 Diabetic dermopathy was one found in one 
patient in present study. Its incidence may range from 
7% to 70% in diabetics; more common in older, elderly 
patients with long standing DM.13As we have only 20 
patients with diabetes of more than 20 years duration 
in our study, so its incidence was low. In our study, 
psoriasis was seen in  one patient. Psoriasis has been 
reported in 9% of people with diabetes. Psoriasis may 
increase the predisposition for developing DM later in 
life so clinicians should keep check on patients with 
psoriasis for the presence of DM.7 
None of our patients were found to have necrobiosis 
lipoidica  as it occurs in only 0.3% to 1.6% of diabetic 
patients, diabetic bullae and scleroderma 
diabeticorum, yellow skin,or granuloma annulare. 19 
There were some limitations of our study. Although 
diabetic foot with gangrene is quite common in our 
population, but most of these patients are routinely 
admitted in surgical wards so we could not find these 
patients in large number. As the hospital caters 
patients with low socioeconomic group, so poor 
hygiene and lack of affordability of health services can 
be the reason behind higher  incidence of skin 
infections in our study. 
 
Conclusion 
Early recognition of cutaneous markers not only helps 
in an earlier diagnosis of undiagnosed DM but also 
serves as a sign to recognize suboptimal management 
of known disease.  In time  identification of cutaneous 
manifestations should prompt clinicians to screen for 
pre-diabetes and diabetic states and better glycemic 
control results in a reduction of complications. 
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